Literature DB >> 18178946

Comparison between bicarbonate/lactate and standard lactate dialysis solution in peritoneal transport and ultrafiltration: a prospective, crossover single-dwell study.

Wei Fang1, Robert Mullan, Hemal Shah, Salim Mujais, Joanne M Bargman, Dimitrios G Oreopoulos.   

Abstract

OBJECTIVE: It has been proposed that biocompatible bicarbonate/lactate based (Bic/Lac), physiologic-pH peritoneal dialysis (PD) solutions will be beneficial in long-term PD. However, we do not yet have detailed knowledge concerning the comparative physiology of buffer transport for these new solutions and their impact on underlying peritoneal transport of solutes and ultrafiltration (UF). The purpose of this study was to investigate the profile of buffer handling and peritoneal membrane transport characteristics during a single dwell of the new Bic/Lac-based versus standard lactate-based (Lac) PD solution.
METHODS: In this prospective crossover study, we compared a 25 mmol/L bicarbonate/15 mmol/L lactate buffered, physiologic pH, low glucose degradation product (GDP) solution (Physioneal; Baxter Healthcare, McGaw Park, Illinois, USA) with a standard lactate buffered, acidic pH, conventional solution (Dianeal; Baxter). 18 patients underwent two peritoneal equilibration tests (PETs) with 2.5% Dianeal and 2.5% Physioneal separated by 1 week. Buffer transport, mass transfer area coefficients (MTACs), solute transport, and UF were determined for the two PETs. All bags were weighed by a nurse before instillation and after drainage to assess the net UF in each dwell.
RESULTS: 18 patients that met the inclusion criteria were enrolled in this study. Whereas intraperitoneal pH remained constant at 7.52 +/- 0.11 throughout the dwell with the Bic/Lac solution, pH was still in the acidic range with the Lac solution after 1 hour (7.29 +/- 0.13, p < 0.001); this difference disappeared after the second hour of dwell. The MTACs for creatinine (10.68 +/- 3.66 vs 10.73 +/- 2.96 mL/minute/1.73 m(2), p > 0.05) and urea (27.94 +/- 10.50 vs 27.62 +/- 6.95 mL/min/1.73 m(2), p > 0.05), for Bic/Lac versus Lac respectively, did not differ between these two solutions; transport of glucose and other solutes was also similar. However, after a 4-hour dwell with Bic/Lac solution, net UF was significantly lower than that observed with Lac solution (274.2 +/- 223.3 mL vs 366.1 +/- 217.3 mL, p = 0.026).
CONCLUSIONS: Compared to standard Lac-based solution, Bic/Lac based, pH neutral, low-GDP solution avoids intraperitoneal acidity. Peritoneal mass transport kinetics are similar for small solutes. Net UF is significantly lower with Bic/Lac solution; the mechanism for this is unclear.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18178946

Source DB:  PubMed          Journal:  Perit Dial Int        ISSN: 0896-8608            Impact factor:   1.756


  10 in total

1.  Hydration Status of Patients Dialyzed with Biocompatible Peritoneal Dialysis Fluids.

Authors:  Monika Lichodziejewska-Niemierko; Michał Chmielewski; Maria Dudziak; Alicja Ryta; Bolesław Rutkowski
Journal:  Perit Dial Int       Date:  2015-10-16       Impact factor: 1.756

2.  The impact of dialysis solution biocompatibility on ultrafiltration and on free water transport in rats.

Authors:  Gaëlle Aubertin; Philippe Choquet; Céline Dheu; André Constantinesco; Charline Ratomponirina; Ariane Zaloszyc; Jutta Passlick-Deetjen; Michel Fischbach
Journal:  Pediatr Nephrol       Date:  2011-07-09       Impact factor: 3.714

3.  A study of the clinical and biochemical profile of peritoneal dialysis fluid low in glucose degradation products.

Authors:  Kar Neng Lai; Man Fai Lam; Joseph C K Leung; Loretta Y Chan; Christopher W K Lam; Iris H S Chan; Hoi Wong Chan; Chun Sang Li; Sunny S H Wong; Yiu Wing Ho; Au Cheuk; Matthew K L Tong; Sydney C W Tang
Journal:  Perit Dial Int       Date:  2011-11-03       Impact factor: 1.756

4.  Comparison of Longitudinal Membrane Function in Peritoneal Dialysis Patients According to Dialysis Fluid Biocompatibility.

Authors:  A T N van Diepen; A M Coester; C J Janmaat; F W Dekker; D G Struijk; R T Krediet
Journal:  Kidney Int Rep       Date:  2020-10-10

5.  The effect of low-GDP solution on ultrafiltration and solute transport in continuous ambulatory peritoneal dialysis patients.

Authors:  Kyu-Hyang Cho; Jun-Young Do; Jong-Won Park; Kyung-Woo Yoon; Yong-Lim Kim
Journal:  Perit Dial Int       Date:  2013-01-02       Impact factor: 1.756

Review 6.  Cancer antigen 125 as a biomarker in peritoneal dialysis: mesothelial cell health or death?

Authors:  Harpaul Cheema; Joanne M Bargman
Journal:  Perit Dial Int       Date:  2013 Jul-Aug       Impact factor: 1.756

Review 7.  How peritoneal dialysis transforms the peritoneum and vasculature in children with chronic kidney disease-what can we learn for future treatment?

Authors:  Maria Bartosova; Sotirios G Zarogiannis; Claus Peter Schmitt
Journal:  Mol Cell Pediatr       Date:  2022-05-05

8.  Biocompatible peritoneal dialysis fluids: clinical outcomes.

Authors:  Yeoungjee Cho; Sunil V Badve; Carmel M Hawley; Kathryn Wiggins; David W Johnson
Journal:  Int J Nephrol       Date:  2012-11-28

9.  Biocompatible dialysis fluids for peritoneal dialysis.

Authors:  Htay Htay; David W Johnson; Kathryn J Wiggins; Sunil V Badve; Jonathan C Craig; Giovanni Fm Strippoli; Yeoungjee Cho
Journal:  Cochrane Database Syst Rev       Date:  2018-10-26

10.  Repeated centrifuging and washing concentrates bacterial samples in peritoneal dialysis for optimal culture: an original article.

Authors:  Ni Tien; Bang-Jau You; Hsuan-Jen Lin; Chieh-Ying Chang; Che-Yi Chou; Hsiu-Shen Lin; Chiz-Tzung Chang; Charles C N Wang; Hung-Chih Chen
Journal:  BMC Microbiol       Date:  2020-11-27       Impact factor: 3.605

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.